|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| C07K 7/06 | |||
| C07K 16/28 | |||
| A61K 39/395 | |||
| A61K 38/17 | |||
| G01N 33/50 | |||
| A61P 37/06 | |||
| A61P 37/00 | |||
| A61P 29/00 |
| (11) | Patento numeris | 3224276 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15863095.4 |
| Europos patento paraiškos padavimo data | 2015-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2015/051107 |
| Data | 2015-11-17 |
| (87) | Numeris | WO 2016/084062 |
| Data | 2016-06-02 |
| (30) | Numeris | Data | Šalis |
| 201462083952 P | 2014-11-25 | US |
| (72) |
KARIN, Nathan, IL
WILDBAUM, Gizi, IL
|
| (73) |
Technion Research & Development Foundation Limited,
Senate House Technion City, 3200004 Haifa,
IL
|
| (54) | NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION |
| NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION |